Skip to main content
Top
Published in: Journal of Gastroenterology 11/2012

01-11-2012 | Review

Altered neuro-endocrine–immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model

Authors: Cristina Stasi, Massimo Rosselli, Massimo Bellini, Giacomo Laffi, Stefano Milani

Published in: Journal of Gastroenterology | Issue 11/2012

Login to get access

Abstract

The interaction between the brain and the gut as a pathological mechanism of functional gastrointestinal disorders has been recently recognized in the pathophysiology of the irritable bowel syndrome. Communication between central nervous system and enteric nervous system is two-directional: the brain can influence the function of the enteric nervous system and the gut can influence the brain via vagal and sympathetic afferents. In patients with irritable bowel syndrome, symptoms may be caused by alterations either primarily in the central nervous system (top-down model), or in the gut (bottom-up model), or in a combination of both. The brain–gut axis may be stimulated by various stressors either directed to the central nervous system (exteroreceptive stress) or to the gut (interoceptive stress). Particularly, clinical evidence suggest that in complex and multifactorial diseases such as irritable bowel syndrome, psychological disorders represent significant factors in the pathogenesis and course of the syndrome. Neuroimaging techniques have shown functional differences between central process in healthy subjects and patients with irritable bowel syndrome. Moreover, a high prevalence of psychological/psychiatric disorders have been reported in IBS patients compared to controls. Several data also suggest an alteration of neuro-endocrine and autonomic output to the periphery in these patients. This review will examine and discuss the complex interplay of neuro-endocrine–immune pathways, closely associated with neuropsychiatric disorders.
Literature
2.
go back to reference Straub RH, Herfarth H, Falk W, Andus T, Schölmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis in inflammatory bowel disease? J Neuroimmunol. 2002;126:116–25.PubMedCrossRef Straub RH, Herfarth H, Falk W, Andus T, Schölmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis in inflammatory bowel disease? J Neuroimmunol. 2002;126:116–25.PubMedCrossRef
3.
go back to reference Stasi C, Orlandelli E. Role of the brain–gut axis in the pathophysiology of Crohn’s disease. Dig Dis. 2008;26:156–66.PubMedCrossRef Stasi C, Orlandelli E. Role of the brain–gut axis in the pathophysiology of Crohn’s disease. Dig Dis. 2008;26:156–66.PubMedCrossRef
4.
go back to reference Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut. 1999;45:1–5.CrossRef Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut. 1999;45:1–5.CrossRef
5.
go back to reference Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.PubMedCrossRef Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.PubMedCrossRef
6.
go back to reference Lovallo WR, Thomas TL. Stress hormones in psychophysiological research: emotional, behavioral, and cognitive implications. In: Cacioppo JT, Tassinary LG, Berntson GG, editors. Handbook of psychophysiology. Cambridge: Cambridge University Press; 2000. p. 342–67. Lovallo WR, Thomas TL. Stress hormones in psychophysiological research: emotional, behavioral, and cognitive implications. In: Cacioppo JT, Tassinary LG, Berntson GG, editors. Handbook of psychophysiology. Cambridge: Cambridge University Press; 2000. p. 342–67.
7.
go back to reference Lea R, Whorwell PJ. New insights into the psychosocial aspects of irritable bowel syndrome. Curr Gastroenterol Rep. 2003;5:343–50.PubMedCrossRef Lea R, Whorwell PJ. New insights into the psychosocial aspects of irritable bowel syndrome. Curr Gastroenterol Rep. 2003;5:343–50.PubMedCrossRef
8.
go back to reference Lydiard RB, Fossey MD, Marsh W, Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 1993;34:229–34.PubMedCrossRef Lydiard RB, Fossey MD, Marsh W, Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 1993;34:229–34.PubMedCrossRef
9.
go back to reference Thijssen AY, Jonkers DM, Leue C, van der Veek PP, Vidakovic-Vukic M, van Rood YR, et al. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol. 2010;44:e236–41.PubMedCrossRef Thijssen AY, Jonkers DM, Leue C, van der Veek PP, Vidakovic-Vukic M, van Rood YR, et al. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol. 2010;44:e236–41.PubMedCrossRef
10.
go back to reference Delvaux M, Denis P, Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility. Eur J Gastroenterol Hepatol. 1997;9:345–52.PubMedCrossRef Delvaux M, Denis P, Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility. Eur J Gastroenterol Hepatol. 1997;9:345–52.PubMedCrossRef
11.
go back to reference Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut. 1998;43:256–61.PubMedCrossRef Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut. 1998;43:256–61.PubMedCrossRef
12.
go back to reference O’Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain–gut axis dysfunction. Psychopharmacology (Berl). 2011;214:71–88.CrossRef O’Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain–gut axis dysfunction. Psychopharmacology (Berl). 2011;214:71–88.CrossRef
13.
go back to reference Irwin C, Falsetti SA, Lydiard RB, Ballenger JC, Brock CD, Brener W. Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry. 1996;57:576–8.PubMedCrossRef Irwin C, Falsetti SA, Lydiard RB, Ballenger JC, Brock CD, Brener W. Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry. 1996;57:576–8.PubMedCrossRef
14.
go back to reference Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy with irritable bowel syndrome. Gut. 1990;31:896–8.PubMedCrossRef Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy with irritable bowel syndrome. Gut. 1990;31:896–8.PubMedCrossRef
15.
go back to reference Poitras P, Riberdy Poitras M, Boivin M, Verrier P. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci. 2002;47:914–20.PubMedCrossRef Poitras P, Riberdy Poitras M, Boivin M, Verrier P. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci. 2002;47:914–20.PubMedCrossRef
16.
go back to reference Houghton LA, Calvert EL, Jackson NA, Cooper P, Whorwell PJ. Visceral sensation and emotion: a study using hypnosis. Gut. 2002;51:701–4.PubMedCrossRef Houghton LA, Calvert EL, Jackson NA, Cooper P, Whorwell PJ. Visceral sensation and emotion: a study using hypnosis. Gut. 2002;51:701–4.PubMedCrossRef
17.
go back to reference Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain–gut interactions. Med Sci Monit. 2004;10:RA55–62. Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain–gut interactions. Med Sci Monit. 2004;10:RA55–62.
18.
go back to reference Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997;112:64–72.PubMedCrossRef Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997;112:64–72.PubMedCrossRef
19.
go back to reference Drossman DA, Ringel Y, Vogt BA, Leserman J, Lin W, Smith JK, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology. 2003;124:754–61.PubMedCrossRef Drossman DA, Ringel Y, Vogt BA, Leserman J, Lin W, Smith JK, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology. 2003;124:754–61.PubMedCrossRef
20.
go back to reference Mertz H, Morgan V, Tanner G, Pichens D, Price R, Shyr Y, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842–8.PubMedCrossRef Mertz H, Morgan V, Tanner G, Pichens D, Price R, Shyr Y, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842–8.PubMedCrossRef
21.
go back to reference Baciu MV, Bonaz BL, Papillon E, Bost RA, Le Bas JF, Fournet J, et al. Central processing of rectal pain: a functional MR imaging study. Am J Neuroradiol. 1999;20:1920–4.PubMed Baciu MV, Bonaz BL, Papillon E, Bost RA, Le Bas JF, Fournet J, et al. Central processing of rectal pain: a functional MR imaging study. Am J Neuroradiol. 1999;20:1920–4.PubMed
22.
go back to reference Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, et al. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002;97:654–61.PubMedCrossRef Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, et al. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002;97:654–61.PubMedCrossRef
23.
go back to reference Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992;117:854–66.PubMed Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992;117:854–66.PubMed
24.
go back to reference Gue M, Tekamp A, Tabis N, Junien JL, Buéno L. Cholecystokinin blockade of emotional stress- and CRF-induced colonic motor alterations in rats: role of the amygdala. Brain Res. 1994;658:232–8.PubMedCrossRef Gue M, Tekamp A, Tabis N, Junien JL, Buéno L. Cholecystokinin blockade of emotional stress- and CRF-induced colonic motor alterations in rats: role of the amygdala. Brain Res. 1994;658:232–8.PubMedCrossRef
25.
go back to reference Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides. 2004;38:225–34.PubMedCrossRef Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides. 2004;38:225–34.PubMedCrossRef
26.
go back to reference Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 1983;36:165–86.PubMedCrossRef Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 1983;36:165–86.PubMedCrossRef
27.
go back to reference Taché Y, Monnikes H, Bonaz B, Rivier J. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann NY Acad Sci. 1993;697:233–43.PubMedCrossRef Taché Y, Monnikes H, Bonaz B, Rivier J. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann NY Acad Sci. 1993;697:233–43.PubMedCrossRef
28.
go back to reference Taché Y, Martinez V, Million M, Rivier J. Corticotropin-releasing factor and the brain–gut motor response to stress. Can J Gastroenterol. 1999;13:18A–25A.PubMed Taché Y, Martinez V, Million M, Rivier J. Corticotropin-releasing factor and the brain–gut motor response to stress. Can J Gastroenterol. 1999;13:18A–25A.PubMed
29.
go back to reference Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20:1093–102.PubMedCrossRef Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20:1093–102.PubMedCrossRef
30.
go back to reference Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nat Genet. 1998;19:162–6.PubMedCrossRef Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nat Genet. 1998;19:162–6.PubMedCrossRef
31.
go back to reference Cole MA, Kalman BA, Pace TW, Topczewski F, Lowrey MJ, Spencer RL. Selective blockade of the mineralocorticoid receptor impairs hypothalamic–pituitary–adrenal axis expression of habituation. J Neuroendocrinol. 2000;12:1034–42.PubMedCrossRef Cole MA, Kalman BA, Pace TW, Topczewski F, Lowrey MJ, Spencer RL. Selective blockade of the mineralocorticoid receptor impairs hypothalamic–pituitary–adrenal axis expression of habituation. J Neuroendocrinol. 2000;12:1034–42.PubMedCrossRef
32.
go back to reference Munakata J, Mayer EA, Chang L, Schmulson M, Liu M, Tougas G, et al. Autonomic and neuroendocrine responses to recto-sigmoid stimulation. Gastroenterology. 1998;114:A808.CrossRef Munakata J, Mayer EA, Chang L, Schmulson M, Liu M, Tougas G, et al. Autonomic and neuroendocrine responses to recto-sigmoid stimulation. Gastroenterology. 1998;114:A808.CrossRef
33.
go back to reference Heitkemper M, Jarrett M, Cain K, Shaver J, Bond E, Woods NF, et al. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol. 1996;91:906–13.PubMed Heitkemper M, Jarrett M, Cain K, Shaver J, Bond E, Woods NF, et al. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol. 1996;91:906–13.PubMed
34.
go back to reference Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary–adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001;158:575–81.PubMedCrossRef Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary–adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001;158:575–81.PubMedCrossRef
35.
go back to reference Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.PubMedCrossRef Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.PubMedCrossRef
36.
go back to reference Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci. 1995;771:1–18.PubMedCrossRef Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci. 1995;771:1–18.PubMedCrossRef
37.
go back to reference Spiller RC, Jenkis D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–11.PubMedCrossRef Spiller RC, Jenkis D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–11.PubMedCrossRef
38.
go back to reference Creed F. The relationship between psychosocial parameters and outcome in the irritable bowel syndrome. Am J Med. 1999;107:74–80.CrossRef Creed F. The relationship between psychosocial parameters and outcome in the irritable bowel syndrome. Am J Med. 1999;107:74–80.CrossRef
39.
go back to reference Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–6.PubMedCrossRef Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–6.PubMedCrossRef
40.
go back to reference Aggarwal A, Cutts TF, Abell AL, Cardoso S, Familoni B, Bremer J, et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 1994;106:945–50.PubMed Aggarwal A, Cutts TF, Abell AL, Cardoso S, Familoni B, Bremer J, et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 1994;106:945–50.PubMed
41.
go back to reference Tougas G. The autonomic nervous system in functional bowel disorders. Gut. 2000;47:iv78–80. Tougas G. The autonomic nervous system in functional bowel disorders. Gut. 2000;47:iv78–80.
42.
go back to reference Heitkemper M, Jarret M, Cain KC, Burr R, Levy RL, Feld A, et al. Autonomic nervous system in women with irritable bowel syndrome. Dig Dis Sci. 2001;46:1276–84.PubMedCrossRef Heitkemper M, Jarret M, Cain KC, Burr R, Levy RL, Feld A, et al. Autonomic nervous system in women with irritable bowel syndrome. Dig Dis Sci. 2001;46:1276–84.PubMedCrossRef
43.
go back to reference Elsenbruch S, Orr WC. Diarrhea and constipation-predominant IBS patients in postprandrial autonomic and cortisol responses. Am J Gastroenterol. 2001;96:460–6.PubMedCrossRef Elsenbruch S, Orr WC. Diarrhea and constipation-predominant IBS patients in postprandrial autonomic and cortisol responses. Am J Gastroenterol. 2001;96:460–6.PubMedCrossRef
44.
45.
go back to reference Gupta V, Sheffield D, Verne GN. Evidence for autonomic dysregulation in irritable bowel syndrome. Dig Dis Sci. 2002;47:1716–22.PubMedCrossRef Gupta V, Sheffield D, Verne GN. Evidence for autonomic dysregulation in irritable bowel syndrome. Dig Dis Sci. 2002;47:1716–22.PubMedCrossRef
46.
go back to reference Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol. 2003;98:1354–61.PubMedCrossRef Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol. 2003;98:1354–61.PubMedCrossRef
47.
go back to reference Jarret ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM. Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci. 2003;48:386–94.CrossRef Jarret ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM. Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci. 2003;48:386–94.CrossRef
48.
go back to reference Isgar B, Harman M, Kaye MD, Whorwel PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190–2.PubMedCrossRef Isgar B, Harman M, Kaye MD, Whorwel PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190–2.PubMedCrossRef
49.
go back to reference Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Gut. 2000;47:804–11.CrossRef Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Gut. 2000;47:804–11.CrossRef
50.
go back to reference Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol. 1989;88:70–8.PubMedCrossRef Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol. 1989;88:70–8.PubMedCrossRef
51.
go back to reference Arzubiaga C, Morrow J, Roberts LJ, Biaggioni I. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. J Allergy Clin Immunol. 1991;87:88–93.PubMedCrossRef Arzubiaga C, Morrow J, Roberts LJ, Biaggioni I. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. J Allergy Clin Immunol. 1991;87:88–93.PubMedCrossRef
52.
go back to reference Gui XY. Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol. 1998;13:980–9.PubMedCrossRef Gui XY. Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol. 1998;13:980–9.PubMedCrossRef
53.
go back to reference Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52:595–638.PubMed Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52:595–638.PubMed
54.
go back to reference Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord. 2003;3:S25–34.PubMed Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord. 2003;3:S25–34.PubMed
55.
go back to reference Mertz H. Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gastroenterology. 2002;51:i29–33. Mertz H. Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gastroenterology. 2002;51:i29–33.
56.
go back to reference Mayer EA, Naliboff BD, Chang L. Basic pathophysiologic mechanisms in irritable bowel syndrome. Dig Dis. 2001;19:212–8.PubMedCrossRef Mayer EA, Naliboff BD, Chang L. Basic pathophysiologic mechanisms in irritable bowel syndrome. Dig Dis. 2001;19:212–8.PubMedCrossRef
57.
go back to reference Kim DY, Camilleri M. Serotonin: a mediator of the brain–gut connection. Am J Gastroenterol. 2000;95:2698–709.PubMed Kim DY, Camilleri M. Serotonin: a mediator of the brain–gut connection. Am J Gastroenterol. 2000;95:2698–709.PubMed
58.
go back to reference Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, et al. Association of distinct α2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004;53:829–37.PubMedCrossRef Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, et al. Association of distinct α2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004;53:829–37.PubMedCrossRef
59.
go back to reference Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci. 1980;25:404–13.PubMedCrossRef Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci. 1980;25:404–13.PubMedCrossRef
60.
go back to reference Simrén M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut. 2001;48:20–7.PubMedCrossRef Simrén M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut. 2001;48:20–7.PubMedCrossRef
61.
go back to reference Slater BJ, Plusa SM, Smith AN, Varma JS. Rectal hypersensitivity in the irritable bowel syndrome. Int J Colorectal Dis. 1997;12:29–32.PubMedCrossRef Slater BJ, Plusa SM, Smith AN, Varma JS. Rectal hypersensitivity in the irritable bowel syndrome. Int J Colorectal Dis. 1997;12:29–32.PubMedCrossRef
62.
go back to reference Harraf F, Schmulson M, Saba L, Varma JS. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut. 1998;43:388–94.PubMedCrossRef Harraf F, Schmulson M, Saba L, Varma JS. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut. 1998;43:388–94.PubMedCrossRef
63.
go back to reference Steens J, Van Der Schaar PJ, Penning C, Brussee J, Masclee AA. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome. Neurogastroenterol Motil. 2002;14:241–7.PubMedCrossRef Steens J, Van Der Schaar PJ, Penning C, Brussee J, Masclee AA. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome. Neurogastroenterol Motil. 2002;14:241–7.PubMedCrossRef
64.
go back to reference Tam FSF, Hiller K, Bunce K. Investigation of the 5-HT receptor type involved in inhibition of spontaneous activity of human colonic circular muscle. Br J Pharmacol. 1992;106:25P.CrossRef Tam FSF, Hiller K, Bunce K. Investigation of the 5-HT receptor type involved in inhibition of spontaneous activity of human colonic circular muscle. Br J Pharmacol. 1992;106:25P.CrossRef
65.
go back to reference Evangelista S. Involvement of tachykinins in intestinal inflammation. Curr Pharm Des. 2001;7:19–30.PubMedCrossRef Evangelista S. Involvement of tachykinins in intestinal inflammation. Curr Pharm Des. 2001;7:19–30.PubMedCrossRef
66.
go back to reference Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther. 1997;73:219–63.PubMedCrossRef Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther. 1997;73:219–63.PubMedCrossRef
67.
go back to reference Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther. 1997;73:173–217.PubMedCrossRef Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther. 1997;73:173–217.PubMedCrossRef
68.
go back to reference Leng YX, Wei YY, Chen H, Zhou SP, Yang YL, Duan LP. Alteration of cholinergic and peptidergic neurotransmitters in rat ileum induced by acute stress following transient intestinal infection is mast cell dependent. Chin Med J. 2010;123:227–33.PubMed Leng YX, Wei YY, Chen H, Zhou SP, Yang YL, Duan LP. Alteration of cholinergic and peptidergic neurotransmitters in rat ileum induced by acute stress following transient intestinal infection is mast cell dependent. Chin Med J. 2010;123:227–33.PubMed
69.
go back to reference Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA. 1987;84:2975–9.PubMedCrossRef Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA. 1987;84:2975–9.PubMedCrossRef
70.
go back to reference Palsson OS, Morteau O, Bozymski EM, Woosley JT, Sartor RB, Davies MJ, et al. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig Dis Sci. 2004;49:1236–43.PubMedCrossRef Palsson OS, Morteau O, Bozymski EM, Woosley JT, Sartor RB, Davies MJ, et al. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig Dis Sci. 2004;49:1236–43.PubMedCrossRef
71.
go back to reference Salio C, Lossi L, Ferrini F, Merighi A. Neuropeptides as synaptic transmitters. Cell Tissue Res. 2006;326:583–98.PubMedCrossRef Salio C, Lossi L, Ferrini F, Merighi A. Neuropeptides as synaptic transmitters. Cell Tissue Res. 2006;326:583–98.PubMedCrossRef
72.
go back to reference Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol. 2007;13:3027–30.PubMed Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol. 2007;13:3027–30.PubMed
73.
go back to reference Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef
74.
go back to reference Rodríguez-Fandiño O, Hernández-Ruiz J, Schmulson M. From cytokines to Toll-like receptors and beyond—current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil. 2010;16:363–73.PubMedCrossRef Rodríguez-Fandiño O, Hernández-Ruiz J, Schmulson M. From cytokines to Toll-like receptors and beyond—current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil. 2010;16:363–73.PubMedCrossRef
75.
go back to reference Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913–20.PubMedCrossRef Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913–20.PubMedCrossRef
76.
go back to reference Dinan TG, Quigley EM, Ahmed SM, Scully P, O’Brien S, O’Mahony L, et al. Hypothalamic–pituitary–gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology. 2006;130:304–11.PubMedCrossRef Dinan TG, Quigley EM, Ahmed SM, Scully P, O’Brien S, O’Mahony L, et al. Hypothalamic–pituitary–gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology. 2006;130:304–11.PubMedCrossRef
77.
78.
go back to reference Stasi C, Zignego AL, Laffi G, Rosselli M. The liver–cytokine–brain circuit in interferon-based treatment of patients with chronic viral hepatitis. J Viral Hepatitis. 2011;18:525–32.CrossRef Stasi C, Zignego AL, Laffi G, Rosselli M. The liver–cytokine–brain circuit in interferon-based treatment of patients with chronic viral hepatitis. J Viral Hepatitis. 2011;18:525–32.CrossRef
Metadata
Title
Altered neuro-endocrine–immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model
Authors
Cristina Stasi
Massimo Rosselli
Massimo Bellini
Giacomo Laffi
Stefano Milani
Publication date
01-11-2012
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 11/2012
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0627-7

Other articles of this Issue 11/2012

Journal of Gastroenterology 11/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.